Latest Breaking News On - Serum institute seeks emergency use approval - Page 1 : comparemela.com

Novavax and Serum Institute of India (SII) announced a regulatory submission to the South African Health Products Regulatory Agency for emergency use authorization (EUA) of Novavax' recombinant nanoparticle protein-based COVID-19 vaccine

South-africa
Philippines
Indonesia
India
Stanleyc-erck
Africa-novavax
African-health-products-regulatory-agency
European-union
World-health-organization
Serum-institute
Drug-administration
Serum-institute-seeks-emergency-use-approval